Antibacterial microcins, class II: A review

Author:

Blinkova Larisa P.ORCID,Altshuler Mike L.ORCID,Mironov Andrey Yu.ORCID

Abstract

In medicine, the issue of the use of effective antibacterial substances against drug-resistant microorganisms remains relevant. Most publications on microcins show undoubted prospects for the further development of these pharmacological agents of bacterial origin with multidirectional action (antibacterial, antiviral, antitumor, etc.). One of the features of microcins is their specific inhibitory activity against gram-negative microorganisms (Escherichia, Proteus, Salmonella, Pseudomonas, etc.). This review aimed to briefly summarize current information about one of the groups of microcins (class II) to assess their possible use in practical medicine and scientific research. The review uses sources from the Russian Science Citation Index, Web of Science, Scopus, and PubMed databases.

Publisher

ECO-Vector LLC

Subject

Building and Construction

Reference47 articles.

1. Escherichia coli ST131: a multidrug-resistant clone primed for global domination

2. Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages

3. World Health Organization [Internet]. Lack of new antibiotics threatens global efforts to contain drug-resistant infections. World Health Organization News Release. 2020 [cited 2023 Apr 20]. Available from: https://www.who.int/news-room/detail/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections.

4. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

5. Put a Bow on It: Knotted Antibiotics Take Center Stage

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3